{"ticker": {"uuid": "a69547d0-ffe9-4048-b151-f27c02e7f971", "symbol": "VIVIMEDLAB", "name": "Vivimed Labs Limited", "exchange": "NSI", "country": "IN", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Vivimed Labs postpones board meeting for FY26 results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOdFhxTzdpWURyaE9HSnlUMVdhdjNyZ3FoNm5aZmdIM1lQZGxFcEliT2UzRkRUV0s5UkI0elVjYWpOdUJuRGV6V0VkRzZLU0dRTlhnNnBaMnRaWkJzLUZ4TnZaNU5YRTQzaWppd05FMkxFWWZxTlYzczNLeGxtV3poYXl0eC1WMlFEcVdSR010N0U0MzF6QnBPbUxRYzJPcHozZHNQaGhna3RLbTdiNXc5d0pFeDVIYzNLczZlYWlFbEg5dw?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-30T07:00:00+00:00", "published_display": "30 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs Limited Enters Corporate Insolvency Resolution Process", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPdUNoZU00VVRJVThFWnhuWWtfZlc4NzVBbV9icHF4TVlJUjRnUDJ6TGlCeFQtQzMyX18yMmhxUzRRZTVrUmE4Q09VRENDMHFIbEsySXJlMHp1RmNYQTZsTkFGbWRHUnR2dy1qa1FvRENQOFRYcm5fRE1BZXRzXzVSTWNUczF2UXAwSjE3XzNrZGcxampyU3FMNFpaZ2JnUkxSdElkbDY5ZThIYURHbmFhNURuSHNWb1JFaVBxVWxpNTJ4Zw?oc=5", "source_name": "scanx.trade", "published_at": "2026-04-26T07:00:00+00:00", "published_display": "26 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs Limited Insolvency Process: CIRP Commences 15.04.2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxQemtfc2p1dVVrSmtmaDhVVE9nQmFabmFHVUx6V01rS2p0N0lFeDhZSE03cXNIRG82RzVkYXRFZWhBOEdSNFBpZ19rSl91cjZkV1NWUl9ILXZmM2tFeWRIOGViZF9LMi1lSFlQczB3Rm16Xy1PLTZ2cFJHZkFwMThBZ1JsVC1VWWRQQ2F2b0ZDb3JKOHNkX0daVk1yMk1Ld2tVek5fSzE3MEVPSkVzaHlMY1FneXpITF90VUNtTl9TMkxMRzl5MG02MnNreldzMTVaN1hqaXNrbkx6UmdiLVE?oc=5", "source_name": "scanx.trade", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs Secures High Court Interim Stay on CBI Case and Bank Fraud Declaration", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxNaG51Z0NyQWpEbmtBOHhXZ3BlMFcxczk2TUVxODFKUHQwQmlKcHBkY0RpczVka2p0anphMUJtR3hLOF9fV2VpOEZWQlA3RDAyNmhremJQb2ZJSWQ1eG5tb21oWkJkbVlJTk82YmZZZnNjdlRfREZZckVBbEVHZ3FfSmluNDVsOThWMmtWLThpajRORHpVTzd3WWJ5Qy13bkgwSHRUSDd6ZzBJUkhhRmpvck5XUmVEanlrX1JFckhKcjNRQVVJS21ncnNIUXV5a3U5MTlF?oc=5", "source_name": "scanx.trade", "published_at": "2026-02-15T08:00:00+00:00", "published_display": "15 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs Limited's (NSE:VIVIMEDLAB) 31% Dip In Price Shows Sentiment Is Matching Revenues", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-09T08:00:00+00:00", "published_display": "09 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs Secures High Court Stay on CBI Proceedings After Search Operations", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxNeVUtcm5oLWVxWE1nSlA3d3lCb1FpSlVmbWctR3dMaXVVTkJBOUNtX1ZPVGJCbFcyVWwyOXZXVThPeTJ5cERLOFRkZEREekgybU9mVGMzUmRiQXpBVkJvaThGXzdWcGRhV0dzVDZFb3hPb0ZRLU9fdmZVcDlKY3ZRMzRuVEVRVVVBZVprRTFUcGNmaHcyZG92T2h2em1hRGRXNlItZF9pWHNfLXhiUDlFdHo4M0t4YjlLRmlIdkhFQXFaU056RTdiMk1XbERrRHpCZ2N2SE5CYlAxdDZYT3Q5SXpJYmFPSTZsM0Jr?oc=5", "source_name": "scanx.trade", "published_at": "2026-02-09T08:00:00+00:00", "published_display": "09 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs Limited Trading Suspension Revoked by BSE and NSE, Trading to Resume December 18", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxOQzltRldPUnI5SnlFTkNNWlNQcmdSOTY3ZlF4TENUWG1lUG9NMmZrdEwxYkhnRlJrVFRodERNQkgtQm9HMUNJMF9MTHhxZmdLZUlVQm5GVzJJSUhRYnpmd1dKblVVa05FbmItNjBBNkNnQk9PdFVNenRXNVlrZ1hEbWdheHNvdkN4aHFlQnNZZjM0dVdaNzVLVjNCaVhod3dWZWRzaGRUWnVSOG9zSGQxNEtlcnpQRzJnY09OT0pyM0U1ZkJIbDZ3LThMdlJoR0tGRXBvTFRJWGZsUUF2VHdv?oc=5", "source_name": "scanx.trade", "published_at": "2025-12-10T08:00:00+00:00", "published_display": "10 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs Ltd. Share Price Today | Vivimed Labs Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMidEFVX3lxTE9HcFJGa0pydUNFMHhHaVZzLTIxTkxaUE51OUxDRmp0ekE3TmlfT3JERGI2M1VJbXlUV0ZEU3p2eVltQVFXQ3Q0NEloLUd1bFRTM0hpX1dzWnRSMFgzWVlqS29sdVhoZlI4My1qTHZwR09RRUJv?oc=5", "source_name": "Value Research", "published_at": "2022-03-25T11:06:53+00:00", "published_display": "25 Mar 2022 11:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs gets DGHS nod to manufacture, market Favipiravir tablets in India", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2021-05-10T07:00:00+00:00", "published_display": "10 May 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs share price up nearly 5% on approval of products", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2020-10-13T07:00:00+00:00", "published_display": "13 Oct 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs Did Not Disclose Transfer and Sale of Business Units, Twice", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOUUd0UE94bFFDOTZjZVQzS25GcXVZVkJLb05oN25waXJ5NjVNTnAxc19kYWFkY0JyWDlXdU5WbklyaXJiSGVpQlpnX2tVZ3FnS0ttRFY2RUhfcE5odmRoRjFNZXBURmFIVFgxNkdFenhGX2NwQldPLTRITzVIUlZJLUZaM0tjQ0t4ODh4cFR1RTNHZDRZRWhmRWo1anNCWDYzMy1tbUdmdHQ1SUFFU3NVeXhHWFhIdw?oc=5", "source_name": "Moneylife", "published_at": "2019-09-10T07:00:00+00:00", "published_display": "10 Sep 2019 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OrbiMed invests $42.5 mn in Vivimed\u2019s bulk-drugs unit", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNWjlKbkxsTkhaT0dVcFZ5azNjeEo0aHA5STJQcmk1Y3gwVEtra3A4Tnp5RE1YeElXOXpSd05ySjFXWFVZQ2NZMWE5bVAtTUFCc1R3Nlp0OVJCNjUwQXMxaVRTNkQ0UDNvLUNDMm53eDl3c253SGxHQW1kN0hvTkhDdHd3?oc=5", "source_name": "VCCircle", "published_at": "2017-09-26T07:00:00+00:00", "published_display": "26 Sep 2017 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clariant to acquire a part of Vivimed Labs' personal care portfolio", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2015-10-01T07:00:00+00:00", "published_display": "01 Oct 2015 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed sells part of specialty chemical unit for $57.7M", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQbEJpdnFNeFhqTldLZ1NDSERTeVNyd2ViN3d1NW9DVUhMUV83eXF4bnlDYXQ1QWZUbGpDTXl3Z0tYYVlPck1paGZ4RkJSa0pUOGxkTkxfVl9LTG1RN1NPT1Y1T1BDbXJWM2lhRWJ4M1VMTWFuQW90R2ZjRGpybEdGaA?oc=5", "source_name": "VCCircle", "published_at": "2015-09-30T07:00:00+00:00", "published_display": "30 Sep 2015 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PE-backed Vivimed buys Hyderabad-based Finoso Pharma for $2.8M", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPOVB5N1A4dGw2c3NPWlVwblVsZk90SElaUk5RS3k4ZzJhUW9FSkpDSFkya0h4NUMxakFqNEZpbjlJLXpNQnNBMlJ6RVY4bmxrampWbmZ0Zm1fSzlGOHA1UERNVFFkSFNfbEdVX3gyVGk3Tnlmbmc4a3JJeGREZGtiZkVuUGh2RDd2?oc=5", "source_name": "VCCircle", "published_at": "2013-02-14T08:00:00+00:00", "published_display": "14 Feb 2013 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Vivimed Labs postpones board meeting for FY26 results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOdFhxTzdpWURyaE9HSnlUMVdhdjNyZ3FoNm5aZmdIM1lQZGxFcEliT2UzRkRUV0s5UkI0elVjYWpOdUJuRGV6V0VkRzZLU0dRTlhnNnBaMnRaWkJzLUZ4TnZaNU5YRTQzaWppd05FMkxFWWZxTlYzczNLeGxtV3poYXl0eC1WMlFEcVdSR010N0U0MzF6QnBPbUxRYzJPcHozZHNQaGhna3RLbTdiNXc5d0pFeDVIYzNLczZlYWlFbEg5dw?oc=5", "source_name": "scanx.trade", "published_at": "2026-05-30T07:00:00+00:00", "published_display": "30 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs Limited Enters Corporate Insolvency Resolution Process", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPdUNoZU00VVRJVThFWnhuWWtfZlc4NzVBbV9icHF4TVlJUjRnUDJ6TGlCeFQtQzMyX18yMmhxUzRRZTVrUmE4Q09VRENDMHFIbEsySXJlMHp1RmNYQTZsTkFGbWRHUnR2dy1qa1FvRENQOFRYcm5fRE1BZXRzXzVSTWNUczF2UXAwSjE3XzNrZGcxampyU3FMNFpaZ2JnUkxSdElkbDY5ZThIYURHbmFhNURuSHNWb1JFaVBxVWxpNTJ4Zw?oc=5", "source_name": "scanx.trade", "published_at": "2026-04-26T07:00:00+00:00", "published_display": "26 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs Limited Insolvency Process: CIRP Commences 15.04.2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3gFBVV95cUxQemtfc2p1dVVrSmtmaDhVVE9nQmFabmFHVUx6V01rS2p0N0lFeDhZSE03cXNIRG82RzVkYXRFZWhBOEdSNFBpZ19rSl91cjZkV1NWUl9ILXZmM2tFeWRIOGViZF9LMi1lSFlQczB3Rm16Xy1PLTZ2cFJHZkFwMThBZ1JsVC1VWWRQQ2F2b0ZDb3JKOHNkX0daVk1yMk1Ld2tVek5fSzE3MEVPSkVzaHlMY1FneXpITF90VUNtTl9TMkxMRzl5MG02MnNreldzMTVaN1hqaXNrbkx6UmdiLVE?oc=5", "source_name": "scanx.trade", "published_at": "2026-04-23T07:00:00+00:00", "published_display": "23 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs Secures High Court Interim Stay on CBI Case and Bank Fraud Declaration", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxNaG51Z0NyQWpEbmtBOHhXZ3BlMFcxczk2TUVxODFKUHQwQmlKcHBkY0RpczVka2p0anphMUJtR3hLOF9fV2VpOEZWQlA3RDAyNmhremJQb2ZJSWQ1eG5tb21oWkJkbVlJTk82YmZZZnNjdlRfREZZckVBbEVHZ3FfSmluNDVsOThWMmtWLThpajRORHpVTzd3WWJ5Qy13bkgwSHRUSDd6ZzBJUkhhRmpvck5XUmVEanlrX1JFckhKcjNRQVVJS21ncnNIUXV5a3U5MTlF?oc=5", "source_name": "scanx.trade", "published_at": "2026-02-15T08:00:00+00:00", "published_display": "15 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs Limited's (NSE:VIVIMEDLAB) 31% Dip In Price Shows Sentiment Is Matching Revenues", "summary": "", "url": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxPNHpQV1BXTGlRZEIxeXQzaURfNURaQm1DT09FLXotMmJGMTEzUFhFaHJ6M2gyNjVIS0FDYXpKVE1VTHRnQ3VGZnBzcXRjeG44NFU5LXZSdXdCVHNjSFM0eTBEdF9MOTFEUHJPNGlncUFJSi14eHE0blRCMFV3SnJBMG9tQlRLcUxNZ1VCbzFnb0RQTFpHZVRwLVZRQnlmVHdnbHhaanJfc1VyWnpCRTlFclNTNXg5SGE3TUdVWjZ6QlRuN1owQ0hWc2Y5MWhLOXhBTEF2SUNacUIwaWxDNGp5U2pwMzI1ZGRDcVJUY9IB8gFBVV95cUxPeGkwRy04ZHVpWXZmSDd5QTNUNDhFS2NhZ2xUWXJQT0dDWXRWczdWQ2Z4b0VoVHdUTEN6djlSSE1oWWcyUU11UXNsbnhXVnlGRUh2SV9NMWU4RjJHOU83djFCZ2JYd05mbHhwRmhncVVTTWpSTWR4anp0dEN1YUlJMzM5VUgxenFjSGdfaGwydHAzSkJwOENhSjlxZ1g1VExDenBSMEM3NzYybHJPZFhjd0RHZENYWXhOOWRHblN2SGwxdndSRTFtQ183WWp0S0lfOXYzS3dCNmJEOU9SX1NPSzAtcnBpa3MtWjE3ZElQVUhPQQ?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-09T08:00:00+00:00", "published_display": "09 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs Secures High Court Stay on CBI Proceedings After Search Operations", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxNeVUtcm5oLWVxWE1nSlA3d3lCb1FpSlVmbWctR3dMaXVVTkJBOUNtX1ZPVGJCbFcyVWwyOXZXVThPeTJ5cERLOFRkZEREekgybU9mVGMzUmRiQXpBVkJvaThGXzdWcGRhV0dzVDZFb3hPb0ZRLU9fdmZVcDlKY3ZRMzRuVEVRVVVBZVprRTFUcGNmaHcyZG92T2h2em1hRGRXNlItZF9pWHNfLXhiUDlFdHo4M0t4YjlLRmlIdkhFQXFaU056RTdiMk1XbERrRHpCZ2N2SE5CYlAxdDZYT3Q5SXpJYmFPSTZsM0Jr?oc=5", "source_name": "scanx.trade", "published_at": "2026-02-09T08:00:00+00:00", "published_display": "09 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs Limited Trading Suspension Revoked by BSE and NSE, Trading to Resume December 18", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxOQzltRldPUnI5SnlFTkNNWlNQcmdSOTY3ZlF4TENUWG1lUG9NMmZrdEwxYkhnRlJrVFRodERNQkgtQm9HMUNJMF9MTHhxZmdLZUlVQm5GVzJJSUhRYnpmd1dKblVVa05FbmItNjBBNkNnQk9PdFVNenRXNVlrZ1hEbWdheHNvdkN4aHFlQnNZZjM0dVdaNzVLVjNCaVhod3dWZWRzaGRUWnVSOG9zSGQxNEtlcnpQRzJnY09OT0pyM0U1ZkJIbDZ3LThMdlJoR0tGRXBvTFRJWGZsUUF2VHdv?oc=5", "source_name": "scanx.trade", "published_at": "2025-12-10T08:00:00+00:00", "published_display": "10 Dec 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs Ltd. Share Price Today | Vivimed Labs Live NSE/BSE", "summary": "", "url": "https://news.google.com/rss/articles/CBMidEFVX3lxTE9HcFJGa0pydUNFMHhHaVZzLTIxTkxaUE51OUxDRmp0ekE3TmlfT3JERGI2M1VJbXlUV0ZEU3p2eVltQVFXQ3Q0NEloLUd1bFRTM0hpX1dzWnRSMFgzWVlqS29sdVhoZlI4My1qTHZwR09RRUJv?oc=5", "source_name": "Value Research", "published_at": "2022-03-25T11:06:53+00:00", "published_display": "25 Mar 2022 11:06", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs gets DGHS nod to manufacture, market Favipiravir tablets in India", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2021-05-10T07:00:00+00:00", "published_display": "10 May 2021 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs share price up nearly 5% on approval of products", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Moneycontrol.com", "published_at": "2020-10-13T07:00:00+00:00", "published_display": "13 Oct 2020 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed Labs Did Not Disclose Transfer and Sale of Business Units, Twice", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOUUd0UE94bFFDOTZjZVQzS25GcXVZVkJLb05oN25waXJ5NjVNTnAxc19kYWFkY0JyWDlXdU5WbklyaXJiSGVpQlpnX2tVZ3FnS0ttRFY2RUhfcE5odmRoRjFNZXBURmFIVFgxNkdFenhGX2NwQldPLTRITzVIUlZJLUZaM0tjQ0t4ODh4cFR1RTNHZDRZRWhmRWo1anNCWDYzMy1tbUdmdHQ1SUFFU3NVeXhHWFhIdw?oc=5", "source_name": "Moneylife", "published_at": "2019-09-10T07:00:00+00:00", "published_display": "10 Sep 2019 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "OrbiMed invests $42.5 mn in Vivimed\u2019s bulk-drugs unit", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxNWjlKbkxsTkhaT0dVcFZ5azNjeEo0aHA5STJQcmk1Y3gwVEtra3A4Tnp5RE1YeElXOXpSd05ySjFXWFVZQ2NZMWE5bVAtTUFCc1R3Nlp0OVJCNjUwQXMxaVRTNkQ0UDNvLUNDMm53eDl3c253SGxHQW1kN0hvTkhDdHd3?oc=5", "source_name": "VCCircle", "published_at": "2017-09-26T07:00:00+00:00", "published_display": "26 Sep 2017 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Clariant to acquire a part of Vivimed Labs' personal care portfolio", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "Business Standard", "published_at": "2015-10-01T07:00:00+00:00", "published_display": "01 Oct 2015 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vivimed sells part of specialty chemical unit for $57.7M", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxQbEJpdnFNeFhqTldLZ1NDSERTeVNyd2ViN3d1NW9DVUhMUV83eXF4bnlDYXQ1QWZUbGpDTXl3Z0tYYVlPck1paGZ4RkJSa0pUOGxkTkxfVl9LTG1RN1NPT1Y1T1BDbXJWM2lhRWJ4M1VMTWFuQW90R2ZjRGpybEdGaA?oc=5", "source_name": "VCCircle", "published_at": "2015-09-30T07:00:00+00:00", "published_display": "30 Sep 2015 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PE-backed Vivimed buys Hyderabad-based Finoso Pharma for $2.8M", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxPOVB5N1A4dGw2c3NPWlVwblVsZk90SElaUk5RS3k4ZzJhUW9FSkpDSFkya0h4NUMxakFqNEZpbjlJLXpNQnNBMlJ6RVY4bmxrampWbmZ0Zm1fSzlGOHA1UERNVFFkSFNfbEdVX3gyVGk3Tnlmbmc4a3JJeGREZGtiZkVuUGh2RDd2?oc=5", "source_name": "VCCircle", "published_at": "2013-02-14T08:00:00+00:00", "published_display": "14 Feb 2013 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 55, "total_relevant": 15, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 15, "score": 50, "total": 15, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 87, "events": [{"event": "general", "label": "Market update", "weight": 7.3, "count": 12}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.45, "count": 2}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 5.41, "latest_week": "2026-07-10", "one_week_move": -6.6, "four_week_move": -11.6, "twelve_week_move": -30.2, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.251252, "market_dynamics_buy_signal": false, "relative_strength": -19.123689, "fair_value_gap": -3.3, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 7.4441, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-6.6% over one week, -11.6% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 60, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "scanx.trade", "count": 6}, {"label": "VCCircle", "count": 3}, {"label": "simplywall.st", "count": 1}, {"label": "Value Research", "count": 1}, {"label": "The Economic Times", "count": 1}, {"label": "Moneycontrol.com", "count": 1}, {"label": "Moneylife", "count": 1}, {"label": "Business Standard", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 15}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 12}, {"label": "Regulatory and legal", "count": 2}, {"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "87/100 classification confidence."}, {"label": "Company focus", "value": "15", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-6.6% over one week, -11.6% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Vivimed Labs postpones board meeting for FY26 results"}], "updated_at": "2026-07-17T06:54:51.084868+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}